67 related articles for article (PubMed ID: 23893605)
1. Design of NK-2-derived peptides with improved activity against equine sarcoid cells.
Gross S; Wilms D; Krause J; Brezesinski G; Andrä J
J Pept Sci; 2013 Oct; 19(10):619-28. PubMed ID: 23893605
[TBL] [Abstract][Full Text] [Related]
2. Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides.
Wilms D; Andrä J
J Pept Sci; 2017 Jan; 23(1):56-67. PubMed ID: 28066958
[TBL] [Abstract][Full Text] [Related]
3. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
Papo N; Shai Y
Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
[TBL] [Abstract][Full Text] [Related]
4. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine.
Schröder-Borm H; Bakalova R; Andrä J
FEBS Lett; 2005 Nov; 579(27):6128-34. PubMed ID: 16269280
[TBL] [Abstract][Full Text] [Related]
5. Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a.
Joshi S; Bisht GS; Rawat DS; Maiti S; Pasha S
FEBS J; 2012 Oct; 279(20):3776-90. PubMed ID: 22883393
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis.
Hammer MU; Brauser A; Olak C; Brezesinski G; Goldmann T; Gutsmann T; Andrä J
Biochem J; 2010 Apr; 427(3):477-88. PubMed ID: 20187872
[TBL] [Abstract][Full Text] [Related]
7. Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface.
Iwasaki T; Ishibashi J; Tanaka H; Sato M; Asaoka A; Taylor D; Yamakawa M
Peptides; 2009 Apr; 30(4):660-8. PubMed ID: 19154767
[TBL] [Abstract][Full Text] [Related]
8. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
[TBL] [Abstract][Full Text] [Related]
9. Surface antigens on equine sarcoid cells and normal dermal fibroblasts as assessed by xenogeneic antisera.
Brostroöm H; Paulie S; Perlmann P
Res Vet Sci; 1989 Mar; 46(2):172-9. PubMed ID: 2704881
[TBL] [Abstract][Full Text] [Related]
10. Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions.
Vanhoye D; Bruston F; El Amri S; Ladram A; Amiche M; Nicolas P
Biochemistry; 2004 Jul; 43(26):8391-409. PubMed ID: 15222751
[TBL] [Abstract][Full Text] [Related]
11. Anticancer mechanisms of temporin-1CEa, an amphipathic α-helical antimicrobial peptide, in Bcap-37 human breast cancer cells.
Wang C; Zhou Y; Li S; Li H; Tian L; Wang H; Shang D
Life Sci; 2013 May; 92(20-21):1004-14. PubMed ID: 23583573
[TBL] [Abstract][Full Text] [Related]
12. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
Conlon JM; Galadari S; Raza H; Condamine E
Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
[TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines.
Johnstone SA; Gelmon K; Mayer LD; Hancock RE; Bally MB
Anticancer Drug Des; 2000 Apr; 15(2):151-60. PubMed ID: 10901303
[TBL] [Abstract][Full Text] [Related]
14. The activity of LE10 peptide on biological membranes using molecular dynamics, in vitro and in vivo studies.
Antunes E; Azoia NG; Matamá T; Gomes AC; Cavaco-Paulo A
Colloids Surf B Biointerfaces; 2013 Jun; 106():240-7. PubMed ID: 23434718
[TBL] [Abstract][Full Text] [Related]
15. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
16. Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units.
Ma QQ; Dong N; Shan AS; Lv YF; Li YZ; Chen ZH; Cheng BJ; Li ZY
Amino Acids; 2012 Dec; 43(6):2527-36. PubMed ID: 22699557
[TBL] [Abstract][Full Text] [Related]
17. Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.
Han FF; Gao YH; Luan C; Xie YG; Liu YF; Wang YZ
J Dairy Sci; 2013 Jun; 96(6):3471-87. PubMed ID: 23567049
[TBL] [Abstract][Full Text] [Related]
18. Cationic amphiphilic peptides with cancer-selective toxicity.
Schweizer F
Eur J Pharmacol; 2009 Dec; 625(1-3):190-4. PubMed ID: 19835863
[TBL] [Abstract][Full Text] [Related]
19. Design of hybrid β-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity.
Liu Y; Xia X; Xu L; Wang Y
Biomaterials; 2013 Jan; 34(1):237-50. PubMed ID: 23046754
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli.
Mangoni ML; Papo N; Barra D; Simmaco M; Bozzi A; Di Giulio A; Rinaldi AC
Biochem J; 2004 Jun; 380(Pt 3):859-65. PubMed ID: 15032749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
